Siemens - special events at Booth #507

AACC/ASCLS Clinical Lab Expo

Siemens Healthcare Diagnostics will showcase the

combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.

As a leading global clinical diagnostic company, Siemens will demonstrate its wide portfolio of workflow solutions and customer-centred services for today’s laboratories. These products include automation, chemistry, immuno-assay, haemostasis, haematology, microbiology, molecular, blood gas, urinalysis, diabetes, IT and customer care.
A variety of 15-minute presentations will be conducted in the Siemens booth, including:
l    Monitoring Metastatic Breast Cancer: The Serum HER-2/neu Test
l    Paediatric Allergy and Asthma
l    Sepsis: ‘Can Emerging Markers Improve Survival Rates?’
l    MRSA and Beyond
l    Liver Disease: Evolving Perspectives on Diagnosis and Management
l    Point of Care Testing
30 July: Educational workshops
l    Trends in Immunosuppressive Drug Use and Cost Effective Monitoring of Immunosuppressive Drugs at the Local Community Level
l    High Sensitivity Troponin: Delivering Value for Chest Pain Management
l    Trends in Infectious Disease Testing:
    A Conversion of Technologies to Meet the Emerging Threat
l    The A, B, C’s of In Vitro Allergy Testing
l    Non-Invasive Markers of Liver Fibrosis – Why are they Needed?

01.07.2008

Related articles

Photo

Sponsored • New Whitepaper

AI-Enabled Care Pathway: Shifting the Paradigm in Prostate Cancer Diagnosis

Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic…

Photo

Article • Equity, access, and the future of radiotherapy

Radiation oncology: the beam widens

Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the…

Photo

Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…

Subscribe to Newsletter